Ocular Therapeutix (NasdaqGM:OCUL) Update / briefing February 17, 2026 08:00 AM ET Company ParticipantsArshad Khanani - Director of Clinical ResearchBill Slattery Jr. - VP of Investor RelationsDarius Moshfeghi - Chief of the Retina DivisionPravin Dugel - Executive Chairman, President and CEOConference Call ParticipantsBiren Amin - Equity Research AnalystTara Bancroft - Equity Research AnalystTazeen Ahmad - Equity Research AnalystOperatorGood morning, and welcome to the Ocular Therapeutix SOL-1 Top Line Data ...